Investigating the effect of migrafar (Tanacetum parthenium) on migraine pain in children are treating with amitriptyline
Phase 3
Completed
- Conditions
- Headache, migraine.Migraine
- Registration Number
- IRCT20220124053815N1
- Lead Sponsor
- Shahre-kord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Definitive diagnosis of primary headache
Mild to moderate headache intensity
Age range from 6 to 18 years
Absence of secondary cause for headache
Not taking any other medicine for headache
Exclusion Criteria
Uncertain diagnosis of headache
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The intensity of the headache will be measured by Visual Scale Questionnaire (VAS). Timepoint: At the beginning and three months after taking the medicine, we check the result. Method of measurement: Visual Analogue Scale.
- Secondary Outcome Measures
Name Time Method umber of headaches. Timepoint: At the beginning of the research and three months after receiving the drug. Method of measurement: Number of daily headaches.;Type of headache. Timepoint: At the beginning of the research and three months after receiving the drug. Method of measurement: To be pulsatile or non-pulsatile.;Location of headache. Timepoint: At the beginning of the research and three months after receiving the drug. Method of measurement: Unilateral or bilateral.